The light-induced decrease in frequency in <i>En1</i>-Arch cords is due to a ventral, nonglutamatergic mechanism and is similar in <i>En1</i>-Arch and <i>En1</i>-Arch-tdT spinal co... by Melanie Falgairolle (759132)

Opposite regulation of <i>chd</i> by <i>hairy2a</i> or <i>braEnR</i> depending on the D by Cecilia E. Aguirre (287180)

Spatial and temporal distribution of pseudorosettes in <i>rd16;Nrl^−/−</i> retina. by Shannon E. Boye (248303)

“…ONH is centered in the drawing. Integrated <i>en face</i> image of the central region of a P41 <i>rd16;Nrl^−/−</i> mouse showing how pseudorosettes appear as white dots (B, right panel, red circle). …”

ERR2/3 promote a gamma motor neuron-like biophysical signature in chick through transcriptional activation. by Mudassar N. Khan (14290428)

“…No decrease in rheobase upon ERR2:EnR (<i>n</i> = 17) transfection. …”

Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: A nationwide study of 5,249 patients in the Danish DD2 cohort by Diana H. Christensen (8599231)

“…Other important metabolic factors associated with DPN included hypertriglyceridemia ≥1.7 mmol/L: adjusted prevalence ratio (aPR) 1.36 (1.17; 1.59), decreased HDL cholesterol <1.0/1.2 mmol/L (male/female): aPR 1.35 (1.12; 1.62), high-sensitive CRP ≥3.0 mg/L: aPR 1.66 (1.42; 1.94), C-peptide ≥1,550 pmol/L: aPR 1.72 (1.43; 2.07), HbA1c ≥78 mmol/mol: aPR 1.42 (1.06; 1.88), and antihypertensive drug use: aPR 1.34 (1.16; 1.55). …”

Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

“…</p>Methods<p>This prospective, multicenter, open-label, randomized, parallel group trial was conducted at 4 medical institutions between April 2020 and May 2022. A total of 126 ambulatory patients with dyslipidemia receiving statin treatment for more than 4 weeks, aged 20–79 years with fasting triglyceride (TG) levels of ≥177 mg/dl were randomly assigned to 16-week pemafibrate 0.4 mg per day treatment group (PEMA, n = 63) or omega-3 fatty acid ethyl 4 g per day treatment group (OMEGA-3, n = 63). …”

Table_1_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

“…</p>Methods<p>This prospective, multicenter, open-label, randomized, parallel group trial was conducted at 4 medical institutions between April 2020 and May 2022. A total of 126 ambulatory patients with dyslipidemia receiving statin treatment for more than 4 weeks, aged 20–79 years with fasting triglyceride (TG) levels of ≥177 mg/dl were randomly assigned to 16-week pemafibrate 0.4 mg per day treatment group (PEMA, n = 63) or omega-3 fatty acid ethyl 4 g per day treatment group (OMEGA-3, n = 63). …”

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic anal... by Haidong, Wang

Get full text
Get full text
Get full text

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic anal... by Haidong, Wang

Get full text
Get full text
Get full text

Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

“…</p>Methods<p>This prospective, multicenter, open-label, randomized, parallel group trial was conducted at 4 medical institutions between April 2020 and May 2022. A total of 126 ambulatory patients with dyslipidemia receiving statin treatment for more than 4 weeks, aged 20–79 years with fasting triglyceride (TG) levels of ≥177 mg/dl were randomly assigned to 16-week pemafibrate 0.4 mg per day treatment group (PEMA, n = 63) or omega-3 fatty acid ethyl 4 g per day treatment group (OMEGA-3, n = 63). …”

Table_1_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

“…</p>Methods<p>This prospective, multicenter, open-label, randomized, parallel group trial was conducted at 4 medical institutions between April 2020 and May 2022. A total of 126 ambulatory patients with dyslipidemia receiving statin treatment for more than 4 weeks, aged 20–79 years with fasting triglyceride (TG) levels of ≥177 mg/dl were randomly assigned to 16-week pemafibrate 0.4 mg per day treatment group (PEMA, n = 63) or omega-3 fatty acid ethyl 4 g per day treatment group (OMEGA-3, n = 63). …”

The expression of α7^GFP changes during different developmental stages of tooth development. by Scott W. Rogers (271631)

“…Bars = 100 µm (A–J); 50 µm (L).</p>…”

Developmental analysis of Brn3b+ neurons in the dorsal midbrain using the <i>Brn3b</i>^GFP/+ mouse. by Hyoseo Lee (17419987)

“…(<b>G</b>) Quantification of GFP+ neurons (<b>iii</b>) and their distribution (<b>iv</b>) showed no obvious differences at E16 (2,306.9 ± 83.7/mm² for <i>Brn3b</i> ^GFP/+, 2,319.6 ± 56.6/mm² for <i>Brn3b</i> ^GFP/flox:: <i>En1-Cre</i>, <i>n</i> = 3 animals/genotype). …”

Image_2_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.JPEG by Monia Vanessa Dewan (18260473)

Data_Sheet_2_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.docx by Monia Vanessa Dewan (18260473)

Table_2_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.DOCX by Monia Vanessa Dewan (18260473)

Image_1_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.JPEG by Monia Vanessa Dewan (18260473)

Table_1_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.DOCX by Monia Vanessa Dewan (18260473)

Data_Sheet_1_The effect of live-performed music therapy with physical contact in preterm infants on parental perceived stress and salivary cortisol levels.docx by Monia Vanessa Dewan (18260473)

Metabolic changes associated with AN5568 treatment. by Pieter C. Steketee (466154)

“…Numbers at red dots correspond to the following metabolites that were significantly increased <b>1)</b> S-adenosyl-L-methionine (m/z: 398.1374, RT: 18.02 min, 7.67-fold), <b>2)</b> 1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one (m/z: 162.0350, RT: 17.24 min, 46.33-fold), <b>3)</b> 5’-methylthioadenosine (m/z: 297.0896, RT: 7.75 min, 6.17-fold), <b>4)</b> N6-acetyl-L-lysine (m/z: 188.1162, RT: 14.70 min, 2.83-fold), <b>5)</b> adenine (m/z: 135.0546, RT: 7.71 min, 12.55-fold), 6) 4-hydroxy-4-methylglutamate (m/z: 177.0637, RT: 15.3 min, 3.46-fold), 7) N6,N6,N6-trimethyl-L-lysine (m/z: 188.1524, RT: 23.54 min, 7.40-fold), 8) cyclic ADP-ribose (m/z: 541.0608, RT: 16.90 min, 43.78-fold), 9) aminoacetone (m/z: 73.0528, RT: 7.67 min, 12.06-fold), 10) 8-amino-7-oxononanoate (m/z: 187.1208, RT: 13.75 min, 8.43-fold). …”